Ekso Bionics Grants Equity Awards and Updates Severance Terms for Executives

Ekso Bionics Holdings Inc. has approved new equity award grants and severance agreements for executives Scott Davis, Jerome Wong, and Jason Jones. The executives received restricted stock units (RSUs) covering 80,000, 19,500, and 15,000 shares respectively, all of which are fully vested as of the grant date. Additionally, they were granted phantom performance-based RSUs (Phantom PSUs) for 185,000, 40,000, and 32,000 notional shares, which will vest if both a company change in control and a stock price of at least $7.50 are achieved within five years. The new severance agreements provide for continued base salary payments for six months (nine months for Davis) if employment is terminated by the company without cause outside of a change in control period. If termination occurs by the company without cause or by executive resignation for good reason within a change in control period, the executives will receive a lump sum equal to nine months’ base salary (18 months for Davis) and medical coverage for the same period. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ekso Bionics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-033889), on November 07, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here